US 11071778
Combination product for use in tumor vaccination
granted A61KA61K2039/54A61K2039/545
Quick answer
US patent 11071778 (Combination product for use in tumor vaccination) held by DCPRIME B.V. expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DCPRIME B.V.
- Grant date
- Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/54, A61K2039/545, A61K2039/585, A61K2039/6037